Related Experiment Video
Updated: May 22, 2025

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
Effects of Kanamycin on Hearing and Vestibular Function in Multidrug-Resistant Tuberculosis Patients
Prakash Kumar Koirala1, Sushma Kashyap2, Hari Shankar Sharma2
1Respiratory Medicine, Sikkim Manipal Institute of Medical Sciences, Gangtok, Sikkim 737102 India.
Abstract:
Kanamycin, an aminoglycoside antibiotic used to treat multidrug-resistant tuberculosis (MDR-TB), poses a significant risk of ototoxicity, potentially affecting hearing and balance. This study aimed to investigate the impact of kanamycin on auditory and vestibular function in MDR-TB patients focusing on the development of Sensorineural Hearing Loss (SNHL), dizziness, and tinnitus. A cohort of primarily young patients (44.4% aged 19-30, 69.4% female) underwent interviews, tuning fork tests, and Pure Tone Audiometry before and after treatment. Statistical analysis revealed significant associations between kanamycin use SNHL, dizziness, and tinnitus. A substantial proportion of participants experienced hearing loss and balance-related symptoms post-treatment. The findings underscore the need for routine auditory and vestibular monitoring in MDR-TB patients, particularly those at higher risk. Further research on minimizing kanamycin-induced ototoxicity, exploring alternative therapies, and conducting longitudinal studies to assess long-term auditory and vestibular outcomes in MDR-TB treatment.
Insights
Kanamycin treatment for multidrug-resistant tuberculosis (MDR-TB) can cause hearing loss and balance problems. Regular monitoring for auditory and vestibular function is crucial for patients receiving this antibiotic.
Area of Science:
- Ototoxicology
- Infectious Diseases
- Audiology
Background:
- Kanamycin is a critical antibiotic for multidrug-resistant tuberculosis (MDR-TB).
- Aminoglycoside antibiotics, including kanamycin, are known for potential ototoxicity.
- Ototoxicity can manifest as hearing loss and vestibular dysfunction.
Purpose of the Study:
- To investigate the ototoxic effects of kanamycin on auditory and vestibular function in MDR-TB patients.
- To assess the incidence of Sensorineural Hearing Loss (SNHL), dizziness, and tinnitus associated with kanamycin treatment.
- To identify the need for monitoring auditory and vestibular health in MDR-TB patients.
Main Methods:
- A cohort of MDR-TB patients received kanamycin treatment.
- Auditory and vestibular function were assessed using interviews, tuning fork tests, and Pure Tone Audiometry.
- Assessments were conducted before and after kanamycin treatment.
Main Results:
- Kanamycin use was significantly associated with Sensorineural Hearing Loss (SNHL).
- A substantial proportion of patients reported dizziness and tinnitus post-treatment.
- The study identified a link between kanamycin and adverse auditory and vestibular outcomes.
Conclusions:
- Kanamycin treatment for MDR-TB is associated with significant risks of ototoxicity, including SNHL and vestibular symptoms.
- Routine auditory and vestibular monitoring is recommended for MDR-TB patients undergoing kanamycin therapy.
- Further research is needed to mitigate kanamycin-induced ototoxicity and explore alternative treatments.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Hearing
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Drugs that Destabilize Microtubules

